Union Minister of Commerce and Industry, Piyush Goyal, held an interaction with key stakeholders from India's pharmaceutical ecosystem, focusing on strengthening industry growth and regulatory reforms.
European countries are expected to face the most immediate and severe impact from the new U.S. tariffs on imported branded or patented pharmaceutical products, while India may remain less affected for now, according to a press release by the Global Trade Research Initiative (GTRI).
Indian pharmaceutical major Piramal Pharma Limited has announced a USD 90 million investment plan towards expanding two of the Company's US facilities.